baber/WOPTO huggingface dataset:
Patent AT-E241705-T1 (AT)
Inventor: BEURET PIERRE
IPC: C21D9/00
Filed: 1998-10-23
Granted: 2003-06-15
Abstract: Installation for thermal treatment of metallic parts comprises: a first assembly with at least one furnace, and a second assembly with at least one jig; one of the two assemblies is attached to a fixed structure (12) and the other assembly is connected to a moving structure (13) relatively to the fixed structure; couplings (16,17,18) are arranged between the two assemblies for placing one jig (6,7) facing one furnace while avoiding oxidation of the metallic part surface.
Patent AT-E229628-T1 (AT)
Inventor: VOLTOLINA FRANCESCO
IPC: F21Y101/00
Filed: 1998-04-21
Granted: 2002-12-15
Abstract: A lighting fixture with arms, comprising at least a central body, a plurality of protruding radial arms and clutching means for fastening said arms to the central body and for the electric connection of the bulb-carrying arms, comprising a fixed element (1) connected to said central body and a movable element (3,3') connected to the end portion of each arm and introduced into the fixed element (1).The movable element (3'), connected to the end of an arm (4) carrying no bulb, is provided at the end portion with a blind tube (25) and the movable element (3), connected to the end of an arm (5) carrying a bulb (6), is provided with two electrical wins (41) connecting a bulb-holder for the bulb (6) to an electric contact means (15,17) that protrudes from the movable element (3) facing the fixed element(1).
Patent AT-E214008-T1 (AT)
Inventor: COFFEY ROBERT THOMAS
IPC: B60N2/015
Filed: 1998-07-07
Granted: 2002-03-15
Abstract: The present invention is a removable vehicle seat assembly for use with a motor vehicle having an interior floor structure with at least a portion thereof covered by a yieldingly deformable material. A latch and release assembly is operatively associated with a riser support structure. The latch and release assembly is configured to be engaged with front and rear anchor members of the interior floor structure and releasably locked in one of a range of releasably locked positions. The latch and release assembly is constructed to be engaged with the front and rear anchor members and releasably locked in an initial one of the range of releasably locked positions. The removable vehicle seat assembly is moved downwardly towards the interior floor structure in response to an application of a downwardly directed force thereto when the latch and release assembly is releasably locked in the initial one of the range of releasably locked positions such that the yieldingly deformable material is yieldingly compressed to a decreased thickness. The latch and release assembly moves progressively from the initial one of the range of releasably locked positions to a subsequent one of the range of releasably locked positions corresponding to the decreased thickness of the yieldingly deformable material during downward movement of the removable vehicle seat assembly. The latch and release assembly is engaged with the front and rear anchor members and releasably locked in the subsequent one of the range of releasably locked positions to thereby prevent upward movement of the removable vehicle seat assembly away from the interior floor structure and to maintain the yieldingly deformable material at the aforesaid decreased thickness.
Patent AT-E214832-T1 (AT)
Inventor: CHANCE ROBERT JAMES
IPC: G10L21/013
Filed: 1998-07-01
Granted: 2002-04-15
Abstract: The characteristics of the speech received by the decoding unit are altered by a processing unit 10 based upon an analysis of the listener's current background noise before the speech is output to enhance its intelligibility to a listener. An analysis unit 12 determines the type and level of the background noise by use of a microphone 13. A decision unit 11 then determines whether the speech currently being received and replayed would be intelligible to an average listener in the current background noise. If unit 11 determines that the speech is readily intelligible then no processing is necessary and the processing unit 10 does not alter the speech which has been passed to it. However, if unit 11 determines that the speech would be unintelligible, then unit 10 alters the speech before passing it to the output to make the speech more intelligible. In a particularly preferred embodiment, the speech characteristics are altered by altering line spectral pair/formant data representing the speech.
Patent AT-E219398-T1 (AT)
Inventor: BENTIVOGLI NERIO
IPC: B25F5/00
Filed: 1998-07-27
Granted: 2002-07-15
Abstract: A rivet gun includes a pneumatic motor (4), that drives a segment stem 7. A pneumatic cylinder (21) actuates a hydraulic cylinder (22) which sends oil under pressure to an expansion chamber (10) provided for moving back the segment stem (7) and buckling the rivet (2) fixing it to a laminate structure (100). The rivet gun also includes a change-over switching device (30) linked to controls (50,60) for reversing rotation of the motor (4). The controls (60) include an inlet valve (61) operated by a trigger (64) for connecting a compressed air infeed duct 14 with a feed-discharge duct (23) leading to the pneumatic cylinder (21). A discharge valve (63) is disposed in series with the inlet valve (61) and has an adjustment ring (176) for adjusting of the maximum traction force. Another discharge valve (90) is disposed in series with the discharge valve (63) previously mentioned and is provided for adjustment of the stroke of the segment stem (7).
Patent AT-E215099-T1 (AT)
Inventor: KOLBE HANNO V J
IPC: A61K9/00
Filed: 1998-07-20
Granted: 2002-04-15
Abstract: The invention concerns novel cationic polymers of formula (I) in which n is a whole number between 0 and 5 and p is a whole number between 2 and 20,000, more particularly p ranges between 10 and 18,000, and advantageously between 200 and 1,000, characterized in that: at least 10%, advantageously 30 to 80%, preferably 70%, of the free NH2 functions are substituted by identical or different hydrophilic R groups; said cationic polymer can further comprise at least a targeting element associated covalently or not with the free NH2 functions and/or said hydrophilic R groups provided that said cationic: polymer contains at least 20%, preferably at least 30%, of free NH2 functions. The invention also concerns a complex comprising at least said cationic polymer associated with at least a therapeutically active substance, in particular a nucleic acid comprising at least a negative charge. The invention is useful for transferring a nucleic acid into target cells, in particular for gene therapy.
Patent AT-E339046-T1 (AT)
Inventor: GORMAN MICHAEL G
IPC: H04L12/28
Filed: 1998-10-28
Granted: 2006-09-15
Abstract: A method and device for distributing both high-speed data service, such as digital computer, video and multimedia data, and lower speed data service, such as POTS voice telephone signals, throughout a customer premises. High-speed digital data and lower speed POTS voice signals are separated by a POTS splitter and distributed throughout the customer premises on separate distribution networks. The lower speed POTS is carried on a wireless distribution network and the high-speed data carried on the existing customer premises wiring ordinarily used for POTS.
Patent AT-E261374-T1 (AT)
Inventor: SCHWARZ KARL
IPC: B65C9/18
Filed: 1999-10-16
Granted: 2004-03-15
Abstract: The method involves feeding a foil-like, thin, continuous strip (1) of label material through a stamping and pick-up station (12) in which each label formed from a region of the strip is stamped out of the strip and picked up by a gripper enclosed by the stamping tool (17) as the residual grid material is carried away. The gripper transports the label to the object and applies it to the object. An Independent claim is also included for an arrangement for producing labels and transferring them to objects.
Patent AT-E226358-T1 (AT)
Inventor: WAMBACH KARSTEN DR
IPC: H05K1/18
Filed: 1999-11-19
Granted: 2002-11-15
Abstract: The module (1) with an outer plate, an inner plate (3) and an intermediate layer with embedded solar cells (6) joined electrically with one another by means of several conductors (8, 9) is characterized by the fact that several such conductors are permanently joined to a common connection system incorporating a multi-polar plug connector (10).
Patent AT-E247758-T1 (AT)
Inventor: SUPERNAT THIERRY
IPC: E05B63/00
Filed: 1999-04-02
Granted: 2003-09-15
Abstract: The operating rod (23) of the locking system is mounted to slide on the front edge of the door (2). A rod driving component (41) moves with the rod and is supported on the bottom (13) and the angles of the groove in order to guide the rod inside a channel. The driving component comprises an opening (27) which is adjusted for the passage of the body (28) of a principal bolt (8) so that the bolt drives the driving component when it is displaced by the control mechanism of the hinge (6).
Patent AT-E336196-T1 (AT)
Inventor: ODRICH MARC
IPC: A61B3/10
Filed: 1999-03-03
Granted: 2006-09-15
Abstract: This invention is an ophthalmic surgery system, and method for treating presbyopia by performing ablative photodecomposition of the corneal surface (200). The offset image of a variable aperture, such as a variable width slit, and variable diameter iris diaphragm, is scanned in a preselected pattern to perform ablative sculpting of predetermined portions of a corneal surface. The scanning is performed to ablate an optical zone sized to match the patient pupil with a peripheral transition zone (216) outside the pupil. The shape of the ablated optical zone is different from the shape of the final optical correction on the anterior surface of the cornea. The optical zone (211) corrects for near vision centrally, and far vision peripherally. A movable image displacement mechanism enables radial displacement, and angular rotation of the profiled beam exiting from the variable aperture. The invention enables wide area treatment with a laser having a narrower beam than the treatment area, and can be used in the treatment of many conditions in conjunction with presbyopia such as hyperopia, hyperopic astigmatism and irregular refractive aberrations.
Patent AT-E288477-T1 (AT)
Inventor: MAEDA TOMOKO
IPC: C12N5/078
Filed: 1999-04-06
Granted: 2005-02-15
Abstract: This invention relates to: a method for differentiating osteoclast precursor cells (preosteoclasts) into osteoclasts, which comprises culturing the preosteoclasts in the absence of accessory cells; a method for isolating preosteoclasts, which comprises culturing peripheral blood or joint fluid in the absence of cytokine for 1 to 3 weeks; an preosteoclasts, which is obtainable by the above method; a method for differentiating the preosteoclasts obtained by the above method into osteoclasts, which comprises culturing the preosteoclasts in the absence of accessory cell; an osteoclast, which is obtainable by the above method; a method for screening agents for treating metabolic bone diseases, which comprises using the preosteoclasts or the osteoclasts as described above; and agents for treating metabolic bone diseases, which is obtainable by the above screening method.
Patent AT-E460896-T1 (AT)
Inventor: MCARTHUR RICHARD
IPC: A61B50/20
Filed: 1999-06-30
Granted: 2010-04-15
Abstract: A surgical instrument holder for use in surgery having a holder body (10) able to hold one of a plurality of surgical instruments used together in surgery, such as a diathermy pencil and a separate suction means or two laproscopic instruments or the like, but allow easy removal of the surgical instruments. A holder attachment means (41) supports the holder body (10) and connects adjacent elongated cylinders (11, 13) at or near respective circumferential points on the elongated cylinders (11, 13) along an intersecting line between respective axes of the adjacent elongated cylinders (11, 13). A connection part (48) associated with the holder attachment means (41) enables the surgical instrument holder (10) to be removably mounted on or near a patient so that the surgical instrument holder (10) provides simultaneous access to each of the adjacent elongated cylinders (11, 13) allowing easy removal of the surgical instruments.
Patent AT-E466100-T1 (AT)
Inventor: BEHR MARCEL
IPC: C12N1/21
Filed: 1999-08-10
Granted: 2010-05-15
Abstract: Specific genetic deletions are identified in mycobacteria isolates, including variations in the  M.tuberculosis  genome between isolates, and numerous deletions present in BCG as compared to  M.tb.  These deletions are used as markers to distinguish between pathogenic and avirulent strains, and as a marker for particular  M.tb  isolates. Deletions specific to vaccine strains of BCG are useful in determining whether a positive tuberculin skin test is indicative of actual tuberculosis infection. The deleted sequences may be re-introduced into BCG to improve the efficacy of the vaccination. Alternatively, the genetic sequence that corresponds to the deletion(s) is deleted from  M.bovis  or  M.tuberculosis  to attenuate the pathogenic bacteria.
Patent AT-E218708-T1 (AT)
Inventor: HELLER ADAM
IPC: G01N33/53
Filed: 1999-08-24
Granted: 2002-06-15
Abstract: <heading lvl="0">Abstract of Disclosure</heading> An electrochemical affinity assay system for detection of ligand-ligand receptor binding.
Patent AT-E233566-T1 (AT)
Inventor: PRAKASH VAIDYA BALENDU
IPC: A61K33/02
Filed: 1999-09-07
Granted: 2003-03-15
Abstract: The present invention relates to a process on ayurvedic preparation comprising in the steps of subjecting silver, mercury, sulphur and arsenic trisulphide to the steps of detoxification, grinding the detoxified mercury and silver in the presence of a citrus juice and then adding detoxified sulphur and again subjecting to the step of grinding to obtain a greyish black powder, adding detoxified arsenic trisulphide thereto and subjecting to the step of grinding, imparting a shape such as a ball thereto, coating the ball with detoxified sulphur in the presence of a citrus juice and subjecting the coated ball to the step of slow firing, adding detoxified arsenic trisulphide and firing, repeating said step of addition and firing ground in a citrus juice such that the weight of the ball is reduced by at least 10% to obtain an intermediate, adding serpentive and delphenium root thereto.
Patent DE-04819036-T1 (DE)
Title: Weiche rotornabe in einer ebene
Inventor: STAMPS FRANK B
IPC: F16F7/00
Filed: 2004-08-27
Abstract: Eine
Kipprotornabe für
ein Kippflügelflugzeug,
wobei die Nabe folgendes umfasst:  ein zentrales Element;  eine
Vielzahl von Blattbefestigungselementen, die zum Befestigen von
Kipprotorblättern
an dem zentralen Element eingerichtet sind, wobei die Blattbefestigungselemente schwenkbar
an dem zentralen Element befestigt sind, zum Schwenken um eine Schwenkachse,
die generell senkrecht zu einer Rotationsebene der Blätter verläuft, wobei das
Schwenken eine Bewegung der Blätter
in der gleichen Ebene relativ zu dem zentralen Element gestattet;
und  einen Dämpfer,
der wirksam mit jedem Blattbefestigungselement verbunden ist, um
die Bewegung des zugehörigen Blatts
in der gleichen Ebene zu dämpfen,
wobei jeder Dämpfer
selektiv zwischen wenigstens ersten und zweiten Federkonstanten
umschaltbar ist.
Patent DE-06748302-T1 (DE)
Title: EPIMERISIERUNG EINER 4y-C-BINDUNG UND MODIFIZIERUNG EINES 14-CH3-(CO)-FRAGMENTS IN ANTHRACYCLIN-ANTIBIOTIKA
Inventor: MATVIENKO VICTOR
IPC: A61K31/65
Filed: 2006-03-06
Abstract: Verfahren zur Zubereitung von Anthracylin mit einer Formel, die durch Formel (1) repräsentiert ist, umfassend:  (a) Bereitstellung von N-Trifluoracetyl Daunorubicin repräsentiert durch Formel (2),  wobei R mit H, OH, oder OMe übereinstimmt und R 2  mit H übereinstimmt;  (b) Reaktion des N-Trifluoracetyl Daunorubicin mit einem aprotischen Lösungsmittel und einem Acylierungsmittel zur Erzeugung eines dazwischenliegenden Sulfoxysalzes, repräsentiert durch Formel (8),  wobei R 2  mit H übereinstimmt;  (c) Behandlung des dazwischenliegenden Sulfoxysalzes mit einer starken Base zur Erzeugung von 4'-Keto-N-Trifluoracetyl-4-R, Daunorubicin aus Formel (3), wobei R 1  mit H, OH oder OMe übereinstimmt;  (d) Reaktion des 4'-Keto-N-Trifluoracetyl-4-R, Daunorubicin mit Borhydrid eines alkalischen Metalls zur Erzeugung von N-Trifluoracetyl-4'-epi-4-R 1 -Daunorubicin, repräsentiert durch Formel (4), wobei R 1  als H, OH, OMe definiert ist;  (e) Hydrolisierendes N-Trifluoracetyl-4'-Epi-4-R 1 -Daunorubicin in einer Basislösung zur Erzeugung von Formel (5), wobei R 1  als H, OH, OMe definiert ist, R 2  mit H übereinstimmt, und An- ein Anion einer starken...
Patent ES-2031051-T1 (ES)
Title: Procedimiento y dispositivo para la verificacion de acontecimientos en un accidente de automovil.
IPC: G01M17/00
Filed: 1991-03-01
Abstract: EL METODO SIRVE PARA CONTROLAR EFECTOS DE UN ACCIDENTE DE AUTOMOVIL, EN EL QUE AL MENOS UN AUTOMOVIL SE DIRIGE A UN PUNTO DE COLISION DEFINIDO ANTERIORMENTE. EL OBJETIVO DE LA INVENCION ES REAJUSTAR UN ACCIDENTE CONCRETO Y QUE DE HECHO, TENGA LUGAR. ESTO SE CONSIGUE AL PONER EN CIRCULACION, PARA REPRODUCIR EL ACCIDENTE, UNO O MAS COCHES CON VELOCIDAD Y DIRECCION CONTROLADA, CORRESPONDIENTE A UN ACCIDENTE YA ACAECIDO EN UNA CALZADA, QUE SE PREFIJA EN LA PRACTICA, Y DADO EL CASO, INCLUYENDO LA INFLUENCIA DEL AMBIENTE.
Patent ES-2126542-T1 (ES)
Title: Procedimiento para la fabricacion de una pieza de retencion para un regulador del cinturon de un sistema de cinturon de seguridad de vehiculos.
Inventor: WIER FRANZ
IPC: B60R22/30
Filed: 1998-02-09
Abstract: LA PRESENTE INVENCION SE REFIERE A UN PROCEDIMIENTO PARA FABRICAR UN COMPONENTE DE BLOQUEO (12) PARA EL REGULADOR DEL CINTURON DE SEGURIDAD DE UN VEHICULO MOTORIZADO. SEGUN LA INVENCION SE PREVEN LOS SIGUIENTES PASOS: SE FABRICA UNA PIEZA DE ALAMBRE (100) DE UNA LONGITUD PREDETERMINADA; LA PIEZA DE ALAMBRE SE ARQUEA PARA DARLE LA FORMA DESEADA; LA PIEZA DE ALAMBRE SE PRENSA A ESCALA.
Patent ES-2167290-T1 (ES)
Inventor: GARBER SHARON R
IPC: G08B13/24
Filed: 1999-08-05
Abstract: The present invention relates to a method of identifying a specific item having an FRID element associated therewith from among a larger group of items also having RFID elements associated therewith, comprising the steps of (a) providing an RFID interrogation device with information identifying the specific item; (b) interrogating the larger group of items; and (c) providing a signal when the RFID device interrogates the RPID tag associated with the specific item; wherein the information provided in step (a) is information identifying a class of items, and step (c) comprises providing a signal when the RFID device interrogates an RFID tag associated with a specific item within that class; and wherein the class of items are items belonging in the same section of the library.
Patent CY-1109926-T1 (CY)
Inventor: PARRINGTON MARK
IPC: A61F2/28
Filed: 2007-10-12
Abstract: The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. The invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. One such foreign DNA sequence is modified CEA nucleic acid.
Patent CY-1108423-T1 (CY)
Inventor: Lindmayer István 
IPC: B65D47/20
Filed: 2008-10-16
Abstract: The cap (10) consists of a lower mounting portion (1) fixed onto the container neck, an upper cover (2) containing the dispensing components e.g. valves, gas-proof sealing elements between cap and bottle, an outlet for pouring liquid and a tube support for a siphon structure. A removable fixing material (27) is provided for preventing dispensing of liquid if necessary.
Patent CY-1113834-T1 (CY)
Inventor: ARVINTE TUDOR
IPC: A61K47/10
Filed: 2012-03-14
Abstract: The invention relates to a liquid formulation comprising a growth hormone or a substance, which stimulates release or potentiates the activity of endogenous hGH; a polyethylene-polypropylene glycol; a citrate/phosphate buffer, an alkali metal salt and an alkaline earth metal salt or a pseudo alkaline earth metal salt, and to a process of preparation thereof.
Patent CY-1112989-T1 (CY)
Inventor: BAGGENSTOS ROGER
IPC: F16L33/207
Filed: 2012-08-01
Abstract: The clamp (1a) has a clamping ring including a circular section along circumference and a radially outwardly extending ear compressible by a tool. The clamping ring is supported in a clamping ring holder (15a). An ear gap cover plate (23) bridges the circular section in an area of a gap of the ear and is attached to the clamping ring holder. The plate has a reference breaking point (24) such that the plate is detached from the ring holder when the clamping ring is pressed, where the breaking point is designed as a film hinge.
Patent CY-1113269-T1 (CY)
Title: Παραγωγα ινδαζολυλ αμιδιου για τη θεραπευτικη αγωγη διαταραχων διαμεσολαβουμενων υπο υποδοχεα γλυκοκορτικοειδων
Inventor: BERGER MARKUS
IPC: C07D417/12
Filed: 2012-08-13
Abstract: Ενώσεις του τύπου (Ι): Η παρούσα εφεύρεση αφορά νέα παράγωγα ινδαζολυλ εστέρα ή αμιδίου, φαρμακευτικές συνθέσεις που περιλαμβάνουν τέτοια παράγωγα, διεργασίες για την παρασκευή τέτοιων νέων παραγώγων και τη χρήση τέτοιων παραγώγων ως φαρμάκων.
Patent CY-1118763-T1 (CY)
Title: Αντισωμα αντι-ερηα2
Inventor: The designation of the inventor has not yet been filed
IPC: C12P21/08
Filed: 2017-03-16
Abstract: Αποκαλύπτονται: αντίσωμα δυνάμενο αναστολής της καρκινοποίησης κυττάρου και/ή της υπερπλασίας κυττάρου όγκου• και άλλων. Συγκεκριμένα αποκαλύπτονται: αντίσωμα το οποίο μπορεί να αναγνωρίσει έναν επίτοπο που μπορεί να αναγνωριστεί από αντίσωμα που παράγεται από υβριδίωμα SH 348-1 (FERM BP-10836) ή υβριδίωμα SH 357-1 (FERM ΒΡ-10837)• αντίσωμα που παράγεται από υβριδίωμα SH 348-1 ή υβριδίωμα SH 357-1• αντίσωμα το οποίο παράγεται από ανθρωποποίηση αντισώματος που παράγεται από υβριδίωμα SH 348-1 ή υβριδίωμα SH 357-1• φαρμακευτικός παράγων που περιλαμβάνει το οποιοδήποτε ένα από τα προαναφερθέντα αντισώματα ως ένα ενεργό συστατικό μίγματος• και άλλα.
Patent CY-1121153-T1 (CY)
Title: Παραγωγα εξενδινης-4 ως διπλοι glp1/gιp- ή τριγωνικοι αγωνιστες glp1/gιp/γλυκαγονης
Inventor: HAACK TORSTEN
IPC: A61K45/06
Filed: 2018-08-09
Abstract: Η παρούσα εφεύρεση σχετίζεται με παράγωγα της εξενδίνης-4 και με την ιατρική χρήση αυτών, για παράδειγμα στη θεραπευτική αντιμετώπιση διαταραχών του μεταβολικού συνδρόμου, συμπεριλαμβανομένων του διαβήτη και της παχυσαρκίας, καθώς και τη μείωση της υπερβολικής πρόσληψης τροφής.
Patent CY-1121000-T1 (CY)
Title: Sirna και χρηση αυτου σε μεθοδους και συνθεσεις για την θεραπεια ή/και προληψη οφθαλμικων καταστασεων
Inventor: JIMENEZ ANTON ANA ISABEL
IPC: C12N15/113
Filed: 2018-08-10
Abstract: Η εφεύρεση αφορά σε μεθόδους και συνθέσεις για τη θεραπεία ή/και πρόληψη οφθαλμικών καταστάσεων που σχετίζονται με υψηλά επίπεδα έκφρασης ή/και δραστικότητας του υποδοχέα βανιλλοειδούς-1 (TRPV).
Patent CY-1121416-T1 (CY)
Title: Yποκατεστημενοι νουκλεοζιτες, νουκλεοτιδια και αναλογα αυτων
Inventor: BEIGELMAN LEONID
IPC: C07H19/16
Filed: 2018-12-13
Abstract: Αποκαλύπτονται στην παρούσα νουκλεοζίτες, νουκλεοσίδια και ανάλογα αυτών, φαρμακευτικές συνθέσεις που περιλαμβάνουν έναν ή περισσότερους νουκλεοζίτες, νουκλεοσίδια και τα ανάλογα αυτών, και μεθόδους σύνθεσης αυτών. Επίσης περιγράφονται στην παρούσα μέθοδοι βελτίωσης και/ή θεραπευτικής αντιμετώπισης μίας πάθησης και/ή μίας κατάστασης, που περιλαμβάνει μία λοίμωξη από έναν παραμυξοϊό και/ή έναν ορθομυξοϊό, μ' έναν νουκλεοζίτη, ένα νουκλεοτίδιο και ένα ανάλογο αυτών.
Patent CY-1122449-T1 (CY)
Title: Σχηματα δοσολογιας ανοσοσυζευγματος enanti-folr1
Inventor: LUTZ ROBERT J
IPC: A61P35/00
Filed: 2019-12-02
Abstract: Παρέχονται μέθοδοι χορήγησης ανοσοσυζευγμάτων που δεσμεύονται με FOLR1. Οι μέθοδοι περιλαμβάνουν χορήγηση ενός ανοσοσυζεύγματος έναντι-FOLR1 σε ένα πρόσωπο που έχει την ανάγκη αυτού, παραδείγματος χάριν σε έναν ασθενή που πάσχει από καρκίνο, σε ένα θεραπευτικά αποτελεσματικό σχήμα δοσολογίας που έχει ως αποτέλεσμα ελάχιστα αρνητικά συμβάντα.